Back to top

Myriad Genetics Inc: (NSDQ: MYGN)

(U.S: NSDQ) As of Aug 1, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$37.12 USD

37.12

+1.02 (2.83%)

Volume: 664,444

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Financial Overview

Fundamental Ratios

P/E
P/E (F1) 17.51
Trailing 12 Months 14.61
PEG Ratio 1.18
EPS Growth
vs. Previous Year 30.43%
vs. Previous Quarter -9.09%
   
Sales Growth
vs. Previous Year 16.91%
vs. Previous Quarter -10.36%
   
Price Ratios
Price/Book 3.65
Price/Cash Flow 18.43
Price / Sales 3.54
ROE
6/30/14 NA
3/31/14 27.78
12/31/13 27.22
ROA
6/30/14 NA
3/31/14 24.78
12/31/13 24.46
Current Ratio
6/30/14 NA
3/31/14 4.69
12/31/13 6.74
Quick Ratio
6/30/14 NA
3/31/14 4.42
12/31/13 6.74
Operating Margin
6/30/14 NA
3/31/14 25.63
12/31/13 25.48
Net Margin
6/30/14 NA
3/31/14 24.45
12/31/13 25.48
Pre-Tax Margin
6/30/14 NA
3/31/14 38.31
12/31/13 39.94
Book Value
6/30/14 NA
3/31/14 9.90
12/31/13 9.04
Inventory Turnover
6/30/14 NA
3/31/14 16.78
12/31/13 31.00
Debt-to-Equity
6/30/14 NA
3/31/14 0.00
12/31/13 0.00
Debt to Capital
6/30/14 NA
3/31/14 0.00
12/31/13 0.00
 

MYGN Chart by YCharts